Garofalo Health Valuation
| GHC Stock | EUR 5.26 0.06 1.13% |
At this time, the firm appears to be overvalued. Garofalo Health Care retains a regular Real Value of €4.51 per share. The prevalent price of the firm is €5.26. Our model calculates the value of Garofalo Health Care from evaluating the firm fundamentals such as Current Valuation of 467.88 M, return on asset of 0.0425, and Return On Equity of 0.0851 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Garofalo Health's price fluctuation is somewhat reliable at this time. Calculation of the real value of Garofalo Health Care is based on 3 months time horizon. Increasing Garofalo Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Garofalo stock is determined by what a typical buyer is willing to pay for full or partial control of Garofalo Health Care. Since Garofalo Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Garofalo Stock. However, Garofalo Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.26 | Real 4.51 | Hype 5.26 |
The real value of Garofalo Stock, also known as its intrinsic value, is the underlying worth of Garofalo Health Care Company, which is reflected in its stock price. It is based on Garofalo Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Garofalo Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Garofalo Health Care helps investors to forecast how Garofalo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Garofalo Health more accurately as focusing exclusively on Garofalo Health's fundamentals will not take into account other important factors: Garofalo Health Total Value Analysis
Garofalo Health Care is currently estimated to have takeover price of 467.88 M with market capitalization of 333.64 M, debt of 116.57 M, and cash on hands of 24.94 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Garofalo Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
467.88 M | 333.64 M | 116.57 M | 24.94 M |
Garofalo Health Investor Information
About 64.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.22. Some equities with similar Price to Book (P/B) outperform the market in the long run. Garofalo Health Care had not issued any dividends in recent years. Garofalo Health Care is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Garofalo Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Garofalo Health has an asset utilization ratio of 44.35 percent. This implies that the Company is making €0.44 for each dollar of assets. An increasing asset utilization means that Garofalo Health Care is more efficient with each dollar of assets it utilizes for everyday operations.Garofalo Health Ownership Allocation
Garofalo Health Care has a total of 89.09 Million outstanding shares. Garofalo Health retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.49 (percent) of Garofalo Health outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Garofalo Health Profitability Analysis
The company reported the revenue of 277.87 M. Net Income was 18.83 M with profit before overhead, payroll, taxes, and interest of 63.24 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Garofalo Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Garofalo Health and how it compares across the competition.
About Garofalo Health Valuation
The stock valuation mechanism determines Garofalo Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Garofalo Health. We calculate exposure to Garofalo Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Garofalo Health's related companies.Garofalo Health Care S.p.A. operates healthcare centers in Italy. It operates 19 healthcare facilities located in Piedmont, Veneto, Tuscany, Emilia-Romagna, Lazio, and Liguria. GAROFALO HEALTH operates under Medical Care Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1187 people.
8 Steps to conduct Garofalo Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Garofalo Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Garofalo Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Garofalo Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Garofalo Health's revenue streams: Identify Garofalo Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Garofalo Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Garofalo Health's growth potential: Evaluate Garofalo Health's management, business model, and growth potential.
- Determine Garofalo Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Garofalo Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Garofalo Stock analysis
When running Garofalo Health's price analysis, check to measure Garofalo Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Garofalo Health is operating at the current time. Most of Garofalo Health's value examination focuses on studying past and present price action to predict the probability of Garofalo Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Garofalo Health's price. Additionally, you may evaluate how the addition of Garofalo Health to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |